Zou S, Wen C, Li F, Jiang L, et al. Nimotuzumab Plus Gemcitabine-based Adjuvant Chemotherapy for Resectable Pancreatic Cancer: A Retrospective Observational Study. Pancreas 2025 Dec 5. doi: 10.1097/MPA.0000000000002511.
PMID: 41359420